The clinical prognostic value of microvascular invasion in non-metastatic renal cell cancer following surgical resection: a systematic review and Meta-analysis
10.3760/cma.j.issn.1000-6702.2018.10.014
- VernacularTitle:微血管侵犯预测非转移性肾癌患者术后生存情况的Meta分析
- Author:
Lijin ZHANG
1
;
Bin WU
;
Zhenlei ZHA
;
Hu ZHAO
;
Yejun FENG
;
Jun YUAN
Author Information
1. 东南大学医学院附属江阴医院泌尿外科
- Keywords:
Carcinoma,renal cell;
Non-metastatic;
Microvascular invasion;
Survival prognosis;
Meta-analysis
- From:
Chinese Journal of Urology
2018;39(10):781-785
- CountryChina
- Language:Chinese
-
Abstract:
Objective To systematically evaluate the expression of microvascular invasion (MVI) in predicting the clinical prognosis of patients with non-metastatic renal cell cancer (nmRCC) after surgical operation.Methods The relevant search strategy,including and excluding criteria for the relevant literature were developed by two independent researchers.Pubmed,EMBASE,China National Knowledge Infrastructure (CNKI),and Wanfang databases were searched from the inception to May 2018 for the study of tumor prognosis in the patients of nmRCC with MVI following surgical resection.The search language was English and Chinese.The methodological quality of the included studies was assessed by the NOS.Stata 12.0 software and Review Manager 5.3 were used to perform a clinical meta-analysis of relevant literature data.Results A total of 25 related clinical studies were included,published from 2004 to 2018.There were 6 741 patients with nmRCC,of which 1 768 cases of MVI,with a proportion rate of 26.2％.The results showed that the patients with MVI in pathological sections had a lower cancer-specific survival rate (CSS) [HR =1.51,95％ CI(1.41-1.62),P ＜0.001],recurrence-free survival rate(RFS) [HR =1.47,95％ CI (1.26-1.71),P＜0.001] and overall survival rate(OS) [HR=1.37,95％C1(1.19-1.57),P＜ 0.001].Egger's publication bias analysis showed no significant publication bias in terms of CSS (t =1.43,P=0.176),RFS (t =1.21,P=0.253) and OS(t =0.37,P=0.725).Conclusions MVI had a significant poor outcome in patients with surgical resection of nmRCC.It can be used as an independent risk factor to evaluate the postoperative prognosis of those patients.
